The potential for inducing hypotension during fentanyl anaesthesia by administering either diltiazem (n = 7) or sodium nitroprusside (n = 7) 
dynamic profile was significantly different between hypotensive agents for MAP (p < 0.02), heart rate (HR) (p < 0.01), SVRI (p < 0.05), and PVRl (p < 0.05). HR was lower with diltiazem than with nitroprusside. A bradycardia less than 50 beats/min was observed in five patients in the diltiazem group. MAP, SVRI and PVRI were lower with nitroprusside than with diltiazem. Diltiazem can induce and maintain moderate hypotension without tachycardia and decreased cardiac output in humans during fentanyl anaesthesia but the modulation of the level of arterial pressure and the depression of atrioventricular conduction are unpredictable.
The anticipated benefits of moderate controlled hypotension during total hip arthroplasties no longer have to be demonstrated. 1,2 Sodium nitroprusside (SNP) is the reference pharmacological agent, 3 but its side effects of potential toxicity, 4 reflex activation of the sympathetic system, ~ and hypertensive rebound on withdrawal 6 encourage research on other controlled hypotension protocols. The literature provides little information about the use of calcium channel blockers to produce hypotension 7 despite their well known vasodilator effects. 8 Cottrel et al. investigated the effect of nifedipine as an IV bolus on systemic haemodynamics and intracranial pressure in the cat. 9 Oates compared the hypotensive actions of SNP and verapamil infusions in the cat.l~ Zimpfer et al. evaluated the haemodynamic effects of an IV bolus injection of verapamil during neuroleptanaesthesia in man in order to reduce impedance to ventricular ejection during the surgical procedure. 11 The potential for inducing hypotension by administering CAN ANAESTH SOC J 1986 / 33:3 / pp308-14 diltiazem intravenously was investigated in the dog under either halothane anaesthesia, ~2 or fentanyl anaesthesia. 1~'~4 Diltiazem has not been tested in patients, t5 since it has been feared that, like verapamil, it might lower arterial pressure by the preponderant lowering of cardiac output. Nifedipine acts more by the lowering of systemic vascular resistance. ~6
This investigation was designed to compare diltiazem with nitroprusside in producing controlled hypotension during total hip arthroplasty and to determine the haemodynamic profiles produced.
Methods
Fourteen patients (ten women and four men), with a mean age of 65 years (range: 48 to 77), had total hip arthroplasties (prosthesis Charnley-Kerboull type), under general anaesthesia.
After premedication (15 mg diazepam po), the patients were taken to the pre-anaesthesia room. Heart rate (HR) was monitored by a CM5 lead. An 18 Gauge Teflon catheter was placed in a radial artery to measure systolic (SAP) and diastolic (DAP) arterial pressures. A 7 F thermodilution catheter was placed via the right jugular vein to measure right atrial pressure (RAP), systolic (SPAP) and diastolic (DPAP) pulmonary medal pressures, pulmonary capillary wedge pressure (PCWP) and cardiac output (CO) (iced injectate in triplicate). Heart rate and pressure were simultaneously recorded on a multi-channel recorder (Mingograf 803 Siemens Elema). Standard formulae were used to calculate mean arterial pressure: MAP = (SAP -DAP)/3 + DAP, cardiac index: CI = CO/BSA, stroke index: SI = CI/HR, systemic vascular resistance index: SVRI = (MAP -RAP)/ CI x 80, and pulmonary vascular resistance index PVRI = (MPAP -PCWP)/CI x 80. PO2, PCO2 (ABL 30 acid-base analyzer radiometer), SO2 and haemoglobin concentration (OSM2 hemoximeter radiometer) were measured in arterial blood and in mixed venous blood. The arterial (CaO2), mixed venous (C~Oz) and capillary (CcO2) contents were calculated using the usual formulae: oxygen content = (SO2 • Hb • 1.34) + PO2 x 0.003, assuming PcO2 = PAO2 and ScOz = 100 per cent. The intrapulmonary shunt was calculated according to the formula: Qs/Qt = CcO2 -CaO2/ CcO2 -C~O2.
Patients were anaesthetized with thiopentone (5 mg.kg -1) and fentanyl (5 ~g.kg-1), intubated after paneuronium injection (0.1 mg'kg -l) and mechanically ventilated. Anaesthesia was maintained with oxygen in nitrous oxide (F1Oz: 0.5). The initial adjustments were adapted to maintain a PaCO2 between 4.5 and 5.2 kPa (35-40 mmHg), with a respiratory frequency of 16 per minute and an I/E ratio = 1/2. Reinjections of fentanyl and pancuronium were systematic, while atropine was not given (0.5 mg IV) unless the HR was less than 50 per minute.
Protocol
An initial measurement of arterial pressure was obtained before anaesthesia in order to define the desired level of hypotension. The aim was to obtain moderate hypotension, equal to 50 per cent of the MAP of the patient when awake, without going below 55 mmHg. Patients were randomly divided into two groups: sodium nitroprusside (n = 7) and diltiazem (n = 7). The hypotensive agent was perfused using a teflon antecubital catheter. The infusion rate of SNP (concentration 200 mg.L -~) was regulated from I to 6 I~g'kg -l "min -I to achieve the desired hypotension. After the standardized injection of 0.15 mg'kg -I of diltiazem during one FIGURE Evolution of the ratio MAP obtained/MAP desired throughout the study. The ratio was one when the goal (a 50 per cent decrease in MAP) was obtained. As the desired MAP was 50 per cent of the MAP of the patient when awake, the ratio was two before and after hypotension.
minute, the further infusion (rate about 5 i~g.kg-1. min-t) was then regulated according to the pressure result obtained. The overall haemodynamic data and the ratio MAP obtained/MAP desired were recorded once the patient was asleep, in the supine position and then in the lateral position, prior to the administration of the hypotensive agent, during its administration (15th and 45th minutes of hypotension, before the first cementing and cessation of the product), and 30 minutes after stopping its administration. Fresh frozen plasma was perfused into a peripheral vein in order to maintain PCWP in the range 8-12 mmHg; red blood cells were begun when blood loss was greater than 300 ml. The intrapulmonary shunt was calculated in the lateral position prior to the administration of the hypotensire agent, 15 minutes after the beginning of its administration, and then before the first cementing. The haemodynamic data are expressed as means ---SD. Statistical analysis was done using ANOVA in order to test the haemodynamic profile within each group; when the variance was significant, a paired t test was used to assess the significance of the changes over time. The analysis of variance then permitted the difference between the two hypotension methods to be determined; when the variance was significant, an unpaired t test was used to localise the difference. Finally, the variance analysis permitted an investigation of interference. Significance was assumed at p values less than 0.05.
Results
Some general information is summarized in Table I . There were no significant differences between the two groups of patients.
The course of the MAP during the investigation is given in Table II . The desired lowering of pressure was identical for both groups ( -46.1 +-6.4 per cent in the diltiazem group and -48 ---1.5 per cent in the nitroprusside group). The figure shows the course of the ratio MAP obtained/MAP desired. A decrease in this ratio was produced by the anaesthetic itself and the changes of body position. With nitroprusside, the desired level of hypotension was reached immediately and was maintained until the first cementing. With diltiazem, the objective was The time course of changes was significantly different between the hypotensive agents for MAP (p < 0.02), HR (p < 0.01), SVRI (p < 0.05), and PVRI (p < 0.05). MAP was significantly lower with nitroprusside than with diltiazem at 15 minutes (p < 0.05) and significantly higher with nitroprusside than with diltiazem 30 min after cessation of the vasodilator (p < 0.02) (Table II) . HR was significantly lower with diltiazem than with nitroprusside at 45 minutes (p < 0.05), and before the first cementing (p < 0.02). The SVRI and PVRI were significantly lower with nitroprusside than with diltiazem at 45 minutes (p < 0.05) and before cementing (p < 0.05).
A significant interaction existed between the use of nitroprusside or diltiazem and the overall course of MAP (p < 0.001) and SVRI (p < 0.05). reached only for the latest points (prior to cementing and before cessation of the infusion), after having doubled, even tripled, the infusion flow (overall dose: 1.125 ---0.250 mg.kg-l; mean dosage: 12.5 • 3 Ixg'kg-l'min-l). Furthermore, the diltiazem infusion had to be stopped on three occasions due to excessive hypotension. Blood pressure rose immediately after the cessation of nitroprusside, while hypotension continued for at least 30 min after the cessation of diltiazem (cessation + 60 minutes: MAP = 76 --. 16 mmHg). The haemodynamic course and the intrapulmonary shunt values during the diltiazem infusion are given in Table HI , and the corresponding results for the nitroprusside group are given in Table IV . Although none of the parameters studied changed significantly in the diltiazem group, bradycardias of less than 50 beats/rain required atropine injections in five of the seven patients; a junctional bradycardia persisted in two of these five patients and diltiazem was then stopped. With sodium nitroprusside, CI and Qs/Qt rose significantly (p < 0.05),
Discussion
In terms of handling or efficacy diltiazem is not comparable to sodium nitroprusside as a controlled hypotension agent for use in anaesthesia. The choice of the initial dosage (IV bolus of 0.15 mg.kg -1 followed by a continuous infusion of 5 p~g.kg -l.min-t) which was as a result of the work of Valette et al. ~7 led to a weak and inconsistent drop in blood pressure. The corresponding plasma levels reported by Valette et al. j7 (145 ng'm1-1 after 20 minutes, and 321 ng'm1-1 after 45 minutes) are nonetheless within the range of therapeutic efficacy.tS-2~ The effect of under-dosage seems to have been avoided since the dosage was doubled, even tripled, during the procedure. Significant hypotension was obtained only after the 60th minute, but there were considerable individual variations. In some cases hypotension did not occur while in others hypotension was too severe. The hypotensive effect was accentuated as time passed, contrary to the study of Pierrot et al. (bolus IV of 0.15 mg.kg-t followed by a continuous infusion of 1 Ixg'kg-t.min -t) in which the effect decreased with time. 2~ Finally, the hypotensive effect was prolonged for at least 60 minutes after cessation of the infusion, in agreement with Bourassa et al. 22 While the persistence of this hypotension before closing of superficial layers may be considered to be harmful, the postoperative course was comparable in both groups. Diltiazem seems to be poorly adapted to the technique of controlled hypotension, contrary to the statement of Griffin et aL la who studied dogs anaesthetized with fentanyl. The dose of diltiazem (30 to 90 Ixg'kg-l'min -l) necessary to obtain a significant drop in systemic vascular resistance (from 3249 -257 to 1138 +--148 dyne.sec.cm -5. m -2) were accompanied by electrophysiological modifications (five of six dogs developed first-degree AV block and four of these five dogs developed 2nd-degree AV block); 13 two dogs had episodes of junctional rhythm. 13 Furthermore negative chronotropic effects appear to be dose-related and HR decreased from 109 ---6.1 to 90 -13 beats/min. 13 In our study smaller doses (12,5 ---3 p,g.kg -I" min -t) led also to bradycardia and junctional rhythm. However, cardiac index increased (from 2.40 +-0.20 to 4.93 -&--0.89 L.min -~'m -2) due to the reduction in afterload, while the dp/dt was little modified, x3
In our study smaller doses resulted in a smaller decrease in SVRI (-28 per cent vs -65 per cent in the study of Griffin et al.) and per se in no increase in CI. Hypotension provoked by diltiazem does not seem, therefore, to be linked to myocardial depression, contrary to what is observed in swine anaesthetized with halothane. 23 Kates et al. 23 demonstrated that blood pressure is reduced by decreasing cardiac output (-42 per cent) without affecting systemic vascular resistance. The hypotensive mechanism appears to be different with anaesthesia using fentanyl, since in the absence of modifications in the conditions of ventricular load, the stroke volume and cardiac output are not modified, despite a known-negative inotropic action. 2'*-26
In conclusion, arterial pressure is difficult to control with diltiazem and the added depression of AV conduction make its use in controlled hypotension during anaesthesia with fentanyl undesirable. On the other hand, diltiazem provides no hamaful effects on cardiac output and produces excellent haemodynamic stability during the recovery period.
